Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MC1R | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
mRNA | PGLYRP1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
mRNA | SUCLA2 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
mRNA | FAM47E | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
mRNA | MED11 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
mRNA | FUK | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
mRNA | SYT1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
mRNA | FASTK | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
mRNA | VN1R1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
mRNA | PLA1A | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |